Changeflow GovPing Healthcare & Life Sciences Laser Acupuncture for Fatigue in Hemodialysis P...
Routine Notice Added Final

Laser Acupuncture for Fatigue in Hemodialysis Patients

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

NIH ClinicalTrials.gov registered a new clinical trial (NCT07538310) evaluating low-level laser acupuncture as a treatment for fatigue in adults with end-stage renal disease undergoing hemodialysis. The randomized controlled study will compare active laser acupuncture to sham treatment over 4 weeks, assessing fatigue severity, quality of life, microcirculation, and autonomic nervous system markers. Participants will be evaluated at baseline, 4 weeks, and 8 weeks.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH ClinicalTrials.gov added a new clinical trial registration (NCT07538310) for a randomized sham-controlled study of low-level laser acupuncture in adults with end-stage renal disease receiving hemodialysis. The trial will enroll participants to receive either active laser acupuncture or a sham procedure 3 times weekly for 4 weeks during regular dialysis sessions, with assessments at baseline, 4 weeks, and 8 weeks. This is a routine registry entry with no compliance obligations for outside parties. Healthcare institutions conducting or considering similar interventional studies involving hemodialysis patients should review the trial protocol for awareness of comparator design and outcome measures.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Laser Acupuncture for Fatigue in Hemodialysis Patients

N/A NCT07538310 Kind: NA Apr 20, 2026

Abstract

The goal of this clinical trial is to learn if laser acupuncture (low-level laser therapy) works to treat fatigue and improve quality of life in adults with end-stage renal disease (ESRD) undergoing hemodialysis. It will also learn about how laser acupuncture affects blood circulation and autonomic nervous system balance.

The main questions it aims to answer are:

  1. Does laser acupuncture reduce the severity of fatigue and its interference with daily life?
  2. Can laser acupuncture improve related symptoms such as insomnia, poor appetite, and skin itching?
  3. How does laser acupuncture affect objective markers like microcirculation and heart rate variability? Researchers will compare laser acupuncture to a sham treatment (a look-alike procedure using a device that does not emit a laser) to see if laser acupuncture works to treat fatigue.

Participants will:

  1. Receive laser acupuncture or a sham treatment during their regular hemodialysis sessions 3 times a week for 4 weeks.
  2. Have their fatigue and life quality assessed through questionnaires on the first day, at 4 weeks, and at 8 weeks.
  3. Undergo non-invasive tests to measure microcirculation, heart rate variability, and pulse waves, and have photos of their tongue taken for Chinese medicine assessment.

Conditions: ESRD (End Stage Renal Disease), Dialysis, Fatigue

Interventions: Low-Level Laser Acupuncture (LA), Sham Laser Acupuncture

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07538310

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Dialysis research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!